Reaction
Infusion Site Abscess reporting signals
As of the last recalculation, Infusion Site Abscess appears in 476 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is TREPROSTINIL (PRR 119.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Treprostinil | 200 | 119.5 | 119.7 |
| Riociguat | 30 | 42.9 | 42.9 |
| Ketoprofen | 12 | 41.0 | 41.0 |
| Sildenafil | 38 | 31.1 | 31.1 |
| Sildenafil Powder, | 24 | 31.0 | 31.0 |
| Macitentan | 44 | 30.5 | 30.5 |
| Tadalafil | 59 | 29.3 | 29.3 |
| Rotigotine | 9 | 27.7 | 27.7 |
| Rasagiline Mesylate | 6 | 23.9 | 23.9 |
| Ambrisentan | 50 | 19.4 | 19.5 |
| Bosentan | 21 | 19.0 | 19.0 |